May 12, 2025
Great insights from our partner, RYVER.AI! 🚀 As synthetic data continues to shape the future of medical AI, understanding the regulatory landscape is more important than ever. Segmed’s latest article takes a thoughtful look at how the FDA is approaching this emerging space and what it means for the future of AI-driven healthcare solutions. Highly recommend giving this a read if you're navigating medical AI development, data generation, or regulatory strategy.
